BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38240833)

  • 1. Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity.
    Tan Q; Joshua AM; Wang M; Bristow RG; Wouters BG; Allen CJ; Tannock IF
    Cancer Chemother Pharmacol; 2024 Jan; ():. PubMed ID: 38240833
    [No Abstract]   [Full Text] [Related]  

  • 2. Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity.
    Tan Q; Joshua AM; Wang M; Bristow RG; Wouters BG; Allen CJ; Tannock IF
    Cancer Chemother Pharmacol; 2017 May; 79(5):959-969. PubMed ID: 28378028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.
    Tan Q; Joshua AM; Saggar JK; Yu M; Wang M; Kanga N; Zhang JY; Chen X; Wouters BG; Tannock IF
    Br J Cancer; 2015 Mar; 112(5):832-40. PubMed ID: 25647012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
    Hansen AR; Tannock IF; Templeton A; Chen E; Evans A; Knox J; Prawira A; Sridhar SS; Tan S; Vera-Badillo F; Wang L; Wouters BG; Joshua AM
    Oncologist; 2019 Sep; 24(9):1188-1194. PubMed ID: 30952818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole promotes the sensitivity of cervical cancer cells to cisplatin by inhibiting cisplatin-induced autophagy.
    Su G; Chen X; Yang H
    J Cancer Res Ther; 2022 Apr; 18(2):362-369. PubMed ID: 35645101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.
    Lu ZN; Shi ZY; Dang YF; Cheng YN; Guan YH; Hao ZJ; Tian B; He HW; Guo XL
    Biomed Pharmacother; 2019 Dec; 120():109478. PubMed ID: 31568987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of autophagy in drug resistance and regulation of osteosarcoma (Review).
    Pu Y; Wang J; Wang S
    Mol Clin Oncol; 2022 Mar; 16(3):72. PubMed ID: 35251623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
    Wöhrer S; Bartsch R; Hejna M; Drach J; Raderer M
    Scand J Gastroenterol; 2005 Oct; 40(10):1222-5. PubMed ID: 16265779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin.
    Brana I; Ocana A; Chen EX; Razak AR; Haines C; Lee C; Douglas S; Wang L; Siu LL; Tannock IF; Bedard PL
    Invest New Drugs; 2014 Dec; 32(6):1269-77. PubMed ID: 25213162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors.
    Tan Q; Wang M; Yu M; Zhang J; Bristow RG; Hill RP; Tannock IF
    Neoplasia; 2016 Jun; 18(6):347-55. PubMed ID: 27292024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
    Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
    Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there any benefit with pantoprazole treatment in infantile hypertrophic pyloric stenosis?
    Fourie N; Arnold M; Banieghbal B; Marchant SL
    Afr J Paediatr Surg; 2022; 19(1):52-55. PubMed ID: 34916353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoprazole Induces Apoptosis of Leukemic Cells by Inhibiting Expression of P-Glycoprotein/Multidrug Resistance-Associated Protein-1 Through PI3K/AKT/mTOR Signaling.
    Liu M; Tang R; Jiang Y
    Indian J Hematol Blood Transfus; 2017 Dec; 33(4):500-508. PubMed ID: 29075060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sestrin2-Mediated Autophagy Contributes to Drug Resistance
    Tang Z; Wei X; Li T; Wang W; Wu H; Dong H; Liu Y; Wei F; Shi L; Li X; Guo Z; Xiao X
    Front Cell Dev Biol; 2021; 9():722960. PubMed ID: 34646824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells.
    Gao J; Wang W
    Chem Biol Interact; 2019 Jan; 297():50-56. PubMed ID: 30365942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.
    Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X
    Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells.
    Tolue Ghasaban F; Maharati A; Akhlaghipour I; Moghbeli M
    Cancer Cell Int; 2023 Apr; 23(1):80. PubMed ID: 37098542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Astragalus polysaccharide may increase sensitivity of cervical cancer HeLa cells to cisplatin by regulating cell autophagy].
    Zhai QL; Hu XD; Xiao J; Yu DQ
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):805-812. PubMed ID: 29600659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
    Goh K; Parasakthi N; Cheah P; Ranjeev C; Rosmawati M; Tan Y; Chin S
    J Gastroenterol Hepatol; 2000 Aug; 15(8):910-4. PubMed ID: 11022833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study.
    Noronha V; Patil V; Menon N; Kalra D; Singh A; Shah M; Goud S; Jobanputra K; Nawale K; Shah S; Chowdhury OR; Mathrudev V; Jogdhankar S; Singh MY; Singh A; Adak S; Sandesh M; Arunkumar R; Kumar S; Mahajan A; Prabhash K
    Med Oncol; 2023 Dec; 41(1):26. PubMed ID: 38129716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.